title: Effect of naloxone on serum luteinizing hormone concentration in anovulatory Holstein cows during the early postpartum period.
abstract: This experiment was conducted to investigate the effect of naloxone (NAL), an opioid receptor antagonist, on pituitary LH secretion in anovulatory Holstein cows during the early postpartum period when cows were expected to be in negative net energy balance. Twenty-three cows (11 primiparous) received either saline (n = 12) or 1 mg/kg BW NAL i.v. (n = 11) on Day 14 or 15 postpartum. Jugular blood samples were collected at 15-min intervals for 2 hr before and 2.5 hr after NAL or saline. All cows received 3 ug gonadotropin releasing hormone (GnRH) at 2.5 hr post-NAL or -saline and blood collection was continued for 1 hr. Mean serum progesterone concentration was 0.33 +/- 0.2 ng/ml. Mean net energy balance for all cows was -5.5 +/- 0.6 Mcal/day. Naloxone caused a transient increase (P < 0.05) in serum LH concentrations in both primi- and multiparous cows within 45 min after administration. In contrast, serum LH concentrations remained unchanged in saline-treated cows. GnRH increased (P < 0.05) LH and there was no effect of treatment. These results suggest that modulation of LH secretion, at least in part, may be mediated via endogenous opioids in dairy cows before first postpartum ovulation.
authors.affiliation: Department of Dairy Science, Virginia Polytechnic Institute and State University, Blacksburg 24061-0315, USA.
authors.forename: A
authors.initials: A
authors.lastname: Ahmadzadeh
authors.forename: M A
authors.initials: MA
authors.lastname: Barnes
authors.forename: R E
authors.initials: RE
authors.lastname: Pearson
mesh_terms: D000818:Animals; D000858:Anovulation / Q000378:metabolism / Q000662:veterinary*; D002417:Cattle / Q000097:blood / Q000502:physiology*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000494:pharmacology; D007986:Luteinizing Hormone / Q000097:blood / Q000378:metabolism*; D015999:Multivariate Analysis; D009270:Naloxone / Q000494:pharmacology*; D009292:Narcotic Antagonists / Q000494:pharmacology*; D010298:Parity; D049590:Postpartum Period / Q000502:physiology*; D011374:Progesterone / Q000097:blood; D011863:Radioimmunoassay / Q000662:veterinary; D011897:Random Allocation
chemical_list: D009292:Narcotic Antagonists; D007987:Gonadotropin-Releasing Hormone; D009270:Naloxone; D011374:Progesterone; D007986:Luteinizing Hormone